PrimeRFP SCOUT · Federal Contract Recompete Brief

W91YTZ19F0196OPTION YR TWO FORT MEADE MEDDAC — Ortho-Clinical Diagnostics, Inc

Ortho-Clinical Diagnostics, Inc holds $57.6M across 1,615 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent V797D60637. The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended Mar 31, 2025 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

W40m Rhco Atlantic
Awarding office
Ortho-Clinical Diagnostics, Inc
Recipient
Mar 31, 2025
PoP end
$2.5M
Obligated
$3.8M
Potential
334516
NAICS
6515
PSC
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Ortho-Clinical Diagnostics, Inc — $90

Contract facts

Federal
Contract numberW91YTZ19F0196
Also listed asW91YTZ-19-F-0196
Also listed asV797D60637-W91YTZ19F0196
AgencyW40m Rhco Atlantic
Awarding officeW40m Rhco Atlantic
Awarding agencyDepartment of Defense (DOD)
Funding agencyDepartment of Defense (DOD)
IncumbentOrtho-Clinical Diagnostics, Inc
CAGE1C0L5
UEIJG5JF2JQJ121
NAICS334516

No full NAICS 334516 intel page yet. Browse NAICS intelligence

PSC6515
Parent IDIQ / IDVV797D60637
Place of performanceFORT GEORGE G MEADE MD
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
Related solicitationW91YTZ19R0090
PoP startJul 10, 2019
PoP end (current)Mar 31, 2025
Obligated$2.5M
Current value$3.8M
Potential value$3.8M

OPTION YR TWO FORT MEADE MEDDAC LAB CHEMISTRY is a federal award for W40m Rhco Atlantic held by Ortho-Clinical Diagnostics, Inc. Estimated value $3.8M ($2.5M obligated). Current period of performance ends Mar 31, 2025. Last award drew 1 bidder. Place of performance: FORT GEORGE G MEADE MD. Related solicitation W91YTZ19R0090.

OPTION YR TWO FORT MEADE MEDDAC LAB CHEMISTRY

Recompete timing

Public
Past PoP end (508 days ago)

Current PoP ended Mar 31, 2025 (508 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Ortho-Clinical Diagnostics, Inc$57.6M obligated across 1,615 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($57.6M) · all agencies
Department of Veterans Affairs (VA)$26.2M · 45%Department of Defense (DOD)$22.1M · 38%Department of Health and Human Services (HHS)$8.6M · 15%General Services Administration (GSA)$297K · 1%
Open full company profile

Related awards

Same parent · incumbent
75H71024F80169
FY2024 LAB VITROS7600 REAGENTS/SUPPLIES TO BE ORDERED ON AN "AS NEEDED" BASIS, PART OF CPT…
$2.1M
Aug 31, 2026
FA466121F0075
VITROS CHEMICAL ANALYZER MAINTENANCE AND CALIBRATION
$336K
Aug 31, 2026
36C25925N0518
BLOOD BANK GEL ANALYZER COST PER TEST - SLC
$114K
Sep 6, 2026
36C25025N0968
BLOOD BANK ANALYZER, REAGENTS AND CONSUMABLES
$239K
Sep 14, 2026
FA489721F0042
CHEM ANALYZER SERVICES - EXERCISE OPTION YEAR 1
$717K
Sep 29, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract W91YTZ19F0196?

W91YTZ19F0196 (OPTION YR TWO FORT MEADE MEDDAC) is a W40m Rhco Atlantic award with a potential value of $3.8M, currently held by Ortho-Clinical Diagnostics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is W91YTZ-19-F-0196?

W91YTZ-19-F-0196 is the dashed form of PIID W91YTZ19F0196 (OPTION YR TWO FORT MEADE MEDDAC), held by Ortho-Clinical Diagnostics, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded W91YTZ19F0196?

W40m Rhco Atlantic awarded W91YTZ19F0196 to Ortho-Clinical Diagnostics, Inc (potential $3.8M).

Who is the incumbent on W91YTZ19F0196?

Ortho-Clinical Diagnostics, Inc is the incumbent with $57.6M across 1615 related awards in SCOUT’s public footprint. The current period of performance ends Mar 31, 2025.

When does Ortho-Clinical Diagnostics, Inc’s W91YTZ19F0196 come up for recompete?

SCOUT tracks a period-of-performance end of Mar 31, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/W91YTZ19F0196